The FDA Warns that Biotin Interferes with Troponin Lab Tests

NewsBiotin Interference
Written By Matthew Yonan
 
fda-logo.jpg
 

November 5th - Today, the FDA issued an updated warning of biotin interference with certain laboratory tests. The FDA remains concerned about certain laboratory tests that have not addressed the risk of biotin interference. For example, the FDA has continued to receive adverse events reports indicating biotin interference caused falsely low troponin results.

Matthew Yonan
Previous

Veravas and Tymora Collaborate on Early Detection Alzheimer’s Testing
Next

Immunoassay Interferences & Their Impact on Patient Care